CompanyAYTUNasdaqDenver, CO

Aytu Biopharma, Inc

Aytu Biopharma develops prescription medicines for central nervous system diseases.

SEC EDGAR ClinicalTrials.gov webcaster5.com

10-KSep 22Latest SEC filing, period to Jun 30

Sep 22Latest story

September 2026

Aytu reports first full launch quarter for EXXUA, fiscal 2026 results

Sep 22Quarterly updateAytu Biopharma, Inc gepirone